HomeNewsInternationalBritain becomes first country to approve Merck's Covid-19 pill molnupiravir

Britain becomes first country to approve Merck’s Covid-19 pill molnupiravir

Britain becomes first country to approve Merck’s Covid-19 pill molnupiravir

Britain has become the first country in the world that has given its approval for a COVID-19 antiviral pill named “Lagevrio (molnupiravir)“. the molnupiravir COVID-19 antiviral pill has been jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics.

  • The Pill will help in fighting against the pandemic Covid-19.

Lagevrio (molnupiravir)

  • The molnupiravir pill is safe and effective and can halve the chances of dying or being hospitalised for those most at risk of developing severe COVID-19 when given early in the illness.

What is molnupiravir: side effects

  • Molnupiravir is from a class of antivirals called mutagenic ribonucleotides that can change the viral genetic material and introduce errors to prevent replication and transcription of the viral genome.
  • Molnupiravir (MK-4482/EIDD-2801) is an investigational, orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2, the causative agent of COVID-19. 

Molnupiravir price

  • The company is yet to declare the price of the antiviral COVID-19 pills.
  • molnupiravir covid
  • side effects of molnupiravir
  • molnupiravir merck
  • molnupiravir approval
  • molnupiravir cost
  • molnupiravir brand name
  • merck
  • ridgeback biotherapeutics

.

đź“Ł Prepare Exams is now on Facebook, Twitter, Instagram, YouTube Channel, and Google News to get all the latest News first Like, Follow and bookmark our website @ PrepareExams.com.

For all the latest Updates, download PrepareExams App.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Latest Articles